More specifically, this reaction is mediated by maternal autoantibodies, of which the predominant types are anti-SSA/Ro52, associated with Sjögren’s syndrome and systemic lupus erythematosus (SLE), as well as women without other symptoms or signs of connective tissue disease. Here, TRIM21 is linked to connective tissue disorder.